Buettner R - Search Results

1

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R. Kahl P, et al. Among authors: buettner r. Cancer Res. 2006 Dec 1;66(23):11341-7. doi: 10.1158/0008-5472.CAN-06-1570. Cancer Res. 2006. PMID: 17145880

2

Cloning and characterization of a second AP-2 transcription factor: AP-2 beta.

Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hofstädter F, Schüle R, Buettner R. Moser M, et al. Among authors: buettner r. Development. 1995 Sep;121(9):2779-88. doi: 10.1242/dev.121.9.2779. Development. 1995. PMID: 7555706

3

Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma.

Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W, Buettner R. Bosserhoff AK, et al. Among authors: buettner r. Cancer Res. 1997 Aug 1;57(15):3149-53. Cancer Res. 1997. PMID: 9242442

4

FHL2, a novel tissue-specific coactivator of the androgen receptor.

Müller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schüle R. Müller JM, et al. Among authors: buettner r. EMBO J. 2000 Feb 1;19(3):359-69. doi: 10.1093/emboj/19.3.359. EMBO J. 2000. PMID: 10654935 Free PMC article.

5

The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.

Müller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R, Schüle R. Müller JM, et al. Among authors: buettner r. EMBO J. 2002 Feb 15;21(4):736-48. doi: 10.1093/emboj/21.4.736. EMBO J. 2002. PMID: 11847121 Free PMC article.

6

Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.

Poser I, Golob M, Weidner M, Buettner R, Bosserhoff AK. Poser I, et al. Among authors: buettner r. Cancer Res. 2002 Oct 15;62(20):5962-6. Cancer Res. 2002. PMID: 12384563

7

Primitive neuroectodermal tumor (PNET) in the differential diagnosis of malignant kidney tumors.

Friedrichs N, Vorreuther R, Poremba C, Schafer KL, Böcking A, Buettner R, Zhou H. Friedrichs N, et al. Among authors: buettner r. Pathol Res Pract. 2002;198(8):563-9. doi: 10.1078/0344-0338-00303. Pathol Res Pract. 2002. PMID: 12390000

8

A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer.

Metzger E, Müller JM, Ferrari S, Buettner R, Schüle R. Metzger E, et al. Among authors: buettner r. EMBO J. 2003 Jan 15;22(2):270-80. doi: 10.1093/emboj/cdg023. EMBO J. 2003. PMID: 12514133 Free PMC article.

9

Neurocytoma arising in the pelvis.

Friedrichs N, Vorreuther R, Fischer HP, Wiestler OD, Buettner R. Friedrichs N, et al. Among authors: buettner r. Virchows Arch. 2003 Aug;443(2):217-9. doi: 10.1007/s00428-003-0852-9. Epub 2003 Jul 3. Virchows Arch. 2003. PMID: 12844263

10

Acute adenoviral infection of a graft by serotype 35 following renal transplantation.

Friedrichs N, Eis-Hubinger AM, Heim A, Platen E, Zhou H, Buettner R. Friedrichs N, et al. Among authors: buettner r. Pathol Res Pract. 2003;199(8):565-70. doi: 10.1078/0344-0338-00463. Pathol Res Pract. 2003. PMID: 14533942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters